植物乳杆菌谷氨酸脱羧酶催化pH范围的理性改造及高效转化生产g-氨基丁酸

γ-氨基丁酸可由谷氨酸脱羧酶(glutamate decarboxylase, GAD)催化谷氨酸一步合成,反应体系成分简单、环境友好。然而,绝大多数GAD酶催化pH偏酸性且反应范围狭小,需要加入无机盐维持最适催化环境,增加了生产附加成分。此外,随着产物γ-氨基丁酸的生成,溶液pH会逐渐上升,不利于GAD酶的持续转化。本研究首先从实验室保藏的一株高产γ-氨基丁酸的植物乳杆菌(Lactobacillus plantarum)中克隆得到谷氨酸脱羧酶LpGAD,基于酶蛋白表面电荷修饰,选择9个位点进行定点突变及组合突变,酶学性质表征结果显示三突变体LpGAD^{S24R/D88R/Y309K}在催化pH区间内酶活力整体提高,尤其拓宽了在偏中性pH 6.0下的酶活,为野生酶的1.68倍。接下来,通过分子动力学模拟解析了酶活提高的机理。此外,将Lpgad与Lpgad^{S24R/D88R/Y309K}突变基因分别在谷氨酸棒杆菌(Corynebacterium glutamicum) E01中过表达,通过优化确定了摇瓶最适转化条件为反应温度40 ℃,菌体量OD₆₀₀=20,底物L-谷氨酸100.0 g/L,5-磷酸吡哆醛添加量为100 μmol/L。5 L发酵罐中,不调节pH,通过分批投料底物L-谷氨酸,γ-氨基丁酸产量高达402.8 g/L,较对照菌株提高了1.63倍。本研究成功拓宽了LpGAD的pH催化范围及酶活,提高了γ氨基丁酸的转化效率,为实现其规模化工业生产奠定了基础。     

滇水金凤转录因子TT8的克隆及表达分析

为探究滇水金凤(Impatiens uliginosa L.)TT8(TRANSPARENT TESTA 8)基因的功能和表达特性,并解析其对滇水金凤花色的影响,研究以滇水金凤花器官为材料,通过RT-PCR等技术克隆IuTT8基因,并对其进行生物信息学分析;利用qRT-PCR分析该基因在不同花色和不同花发育阶段的表达模式。结果表明,(1)成功克隆得到滇水金凤IuTT8基因,其编码区全长为2 136 bp,编码711 aa,为亲水性不稳定蛋白,gDNA全长为3 938 bp,共有6个内含子;结构域分析发现该蛋白属于bHLH超家族成员,与喜马拉雅凤仙花、山茶等物种的TT8蛋白同源且Motif基序相似。(2)IuTT8与同属植物喜马拉雅凤仙花的聚在一支,相似性约86.34%;多序列比对和系统进化分析显示TT8蛋白的结构域高度保守。(3)IuTT8基因在4种不同花色滇水金凤及其4个不同发育阶段均有表达,除白色外,其表达量均随花发育的进行呈先升后降的趋势;且IuTT8基因的表达量与花色呈正相关,其中以深红色表达量最高,白色表达量最低,深红色S3的表达量约为白色S2时期的48倍。研究表明滇水金凤I...     

稀有鮈鲫──一种新的鱼类毒性试验材料

本文研究了稀有鲫（Ｇｏｂｉｏｃｙｐｒｉｓｒａｒｕｓ）作为毒性试验材料的可行性。采用换水式试验,在硬度为２００ｍｇ／Ｌ（以ＣａＣＯ３计）、ｐＨ７．８±０．２、温度２４－２５℃条件下研究了铬、铜、锌和五氯酚（ＰＣＰ）对稀有鲫的急性毒性。重铬酸钾对２日龄稀有鲫的２４ｈ和９６ｈ和ＬＣ５０控制范围分别２６３．６－３３４．７和１１５３－１７８．５ｍｇ／Ｌ（ｎ＝８）。铬、铜、锌和五氯酚对２日龄稀有鲫的急性毒性值（９６ｈＬＣ５０）范围,从铜的５２．２μｇ／Ｌ到铬的５２０００μｇ／Ｌ,毒性大小的顺序是铜＞五氯酚＞锌＞铬。研究结果表明,稀有鲫有可能发展成为一种较为理想的毒性试验材料。     

Glycine metabolomic changes induced by anticancer agents in A549 cells

Amino Acids - Glycine plays a key role in rapidly proliferating cancer cells such as A549 cells. Targeting glycine metabolism is considered as a potential means for cancer treatment. However, the...     

重组枯草芽孢杆菌全细胞催化合成2-O-α-D-甘油葡糖苷

2-O-α-D-甘油葡糖苷是一种在食品、化妆品、保健品及医药领域有着重大应用前景的高附加值产品,但国内仍未实现2-O-α-D-甘油葡糖苷的工业化生产,且鲜有关于2-O-α-D-甘油葡糖苷合成的相关报道。文中旨在开发一种利用食品安全级重组枯草芽孢杆菌全细胞催化合成2-O-α-D-甘油葡糖苷的方法,通过构建一株异源表达肠膜明串珠菌蔗糖磷酸化酶 (Sucrose phosphorylase,SPase) 的重组枯草芽孢杆菌Bacillus subtilis 168/pMA5-gtfA,并将其用作全细胞催化剂合成2-O-α-D-甘油葡糖苷,通过优化培养温度、时间及全细胞转化条件,提高其转化合成2-O-α-D-甘油葡糖苷的产量。结果表明,重组枯草芽孢杆菌B. subtilis 168/pMA5-gtfA在30 ℃下培养20 h,菌体裂解物酶活力最大达1.43 U/mL,并且在1 mol/L蔗糖、2.5 mol/L甘油、pH 7.0、菌体OD600为40、30 ℃下全细胞转化反应48 h,共生成2-O-α-D-甘油葡糖苷189.3 g/L,平均转化速率为15.6 mmol/(L·h),蔗糖转化率约为75.1%,是目前报道的利用重组枯草芽孢杆菌催化合成2-O-α-D-甘油葡糖苷的最高产量,这为2-O-α-D-甘油葡糖苷的工业化生产及应用奠定了理论和实验基础。     

Improving the acidic stability of a β-mannanase from Bacillus subtilis by site-directed mutagenesis

β-Mannanase can randomly hydrolyze the (1→4)-β-d-mannosidic linkages in mannans, galactomannans and glucomannans, yielding manno-oligosaccharides. In this study, the β-mannanase (MAN) from Bacillus subtilis B10-02 was overexpressed successfully in B. subtilis 168 as a hexa-histidine tagged, secreted protein. The recombinant enzyme BsMAN6H was not stable under acidic conditions, which restricts its use in food and feed industry. We aimed to improve the acid stability of BsMAN6H by changing several surface-exposed amino acid residues to acidic or neutral ones. Among the mutations, the His54Asp resulted in a shift in the optimal pH from 6.5 to 5.5. Accordingly, the acid stability was improved by a factor of a negative potential on the structure surface around the mutated site. Furthermore, the H54D variant showed the enzyme activity up to 3207.82 U/mL in bioreactors using the cheap Kojac powder as substrate. As a result, a bacterial β-mannanase was produced efficiently with increased acid stability, improving its applicability in the animal feed industry.     

Insulin-Producing Cells Derived from Human Embryonic Stem Cells: Comparison of Definitive Endoderm- and Nestin-Positive Progenitor-Based Differentiation Strategies

Human embryonic stem cells (hESCs) are pluripotent and capable of undergoing multilineage differentiation into highly specialized cells including pancreatic islet cells. Thus, they represent a novel alternative source for targeted therapies and regenerative medicine for diabetes. Significant progress has been made in differentiating hESCs toward pancreatic lineages. One approach is based on the similarities of pancreatic β cell and neuroepithelial development. Nestin-positive cells are selected as pancreatic β cell precursors and further differentiated to secrete insulin. The other approach is based on our knowledge of developmental biology in which the differentiation protocol sequentially reproduces the individual steps that are known in normal β cell ontogenesis during fetal pancreatic development. In the present study, the hESC cell line PKU1.1 was induced to differentiate into insulin-producing cells (IPCs) using both protocols. The differentiation process was dynamically investigated and the similarities and differences between both strategies were explored. Our results show that IPCs can be successfully induced with both differentiation strategies. The resulting IPCs from both protocols shared many similar features with pancreatic islet cells, but not mature, functional β cells. However, these differently-derived IPC cell types displayed specific morphologies and different expression levels of pancreatic islet development-related markers. These data not only broaden our outlook on hESC differentiation into IPCs, but also extend the full potential of these processes for regenerative medicine in diabetes.